Request Legal Help Now - Free

Advertisement
LAWSUITS NEWS & LEGAL INFORMATION

Levaquin Legal News Articles & Interviews

View Lawyer Interviews only

FDA Announces Levaquin Risks Outweigh Benefits

FDA Announces Levaquin Risks Outweigh Benefits May 13, 2016. By Jane Mundy.
Washington, DC: The FDA today issued a new warning for Levaquin and other fluoroquinolones, adding that side effects of the antibiotic medication “generally” outweigh its benefits.
Read [ FDA Announces Levaquin Risks Outweigh Benefits ]

Johnson & Johnson Faces $800M Levaquin Lawsuit

Johnson & Johnson Faces $800M Levaquin Lawsuit March 5, 2016. By Heidi Turner.
Raritan, NJ: Johnson & Johnson (J&J) reportedly faces an $800 million Levaquin lawsuit, alleging the company hid vital information about side effects linked to the drug. Plaintiffs in the Levaquin antibiotic lawsuit allege Johnson & Johnson, and its subsidiary Janssen Pharmaceuticals, deliberately mislabeled Levaquin. In addition to J&J being named in the lawsuit, former FDA commissioner Margaret Hamberg is also listed and faces allegations of violations of the Racketeer Influenced and Corrupt Organizations (RICO) Act.
Read [ Johnson & Johnson Faces $800M Levaquin Lawsuit ]

Fluoroqinolone Antibiotics Require Black Box Warning for Heart Rhythm Side Effects

Fluoroqinolone Antibiotics Require Black Box Warning for Heart Rhythm Side Effects November 17, 2015. By Lucy Campbell.
Santa Clara, CA: Fluoroqinolone antibiotics, including Levaquin, Avelox and Cipro, should have a new black box warning regarding the risk of heart rhythm problems according to Public Citizen, a prominent national watchdog group.
Read [ Fluoroqinolone Antibiotics Require Black Box Warning for Heart Rhythm Side Effects ]

Levaquin Peripheral Sensorimotor Neuropathy Lawsuits Expected to Grow

Levaquin Peripheral Sensorimotor Neuropathy Lawsuits Expected to Grow July 3, 2015. By Gordon Gibb.
San Francisco, CA It’s bad enough when a prescription medication leaves you with a nasty, but temporary side effect. It’s another thing entirely when a devastating side effect proves permanent. That’s one claim amongst a host of allegations contained in a Levaquin Antibiotics lawsuit currently before the courts and arguing for consolidation by the US Judicial Panel on Multidistrict Litigation.
Read [ Levaquin Peripheral Sensorimotor Neuropathy Lawsuits Expected to Grow ]

Should Levaquin Carry Stronger Warnings?

Should Levaquin Carry Stronger Warnings? December 7, 2014. By Heidi Turner.
Los Angeles, CA Recent concerns about Levaquin side effects have prompted some critics to call on the Food and Drug Administration (FDA) to take stronger action regarding Levaquin. A recent report by ABC10 News highlights some of the concerns medical professionals and patients have about the drug.
Read [ Should Levaquin Carry Stronger Warnings? ]

Levaquin Peripheral Sensorimotor Neuropathy Strikes a Nerve

Levaquin Peripheral Sensorimotor Neuropathy Strikes a Nerve November 14, 2014. By Gordon Gibb.
San Francisco, CA It’s bad enough when a manufacturer is alleged to have known about a potentially serious side effect and didn’t tell anyone about it. When you finally face the music and include Levaquin side effects on product labeling, it helps to be thorough and upfront with just how bad things can get.
Read [ Levaquin Peripheral Sensorimotor Neuropathy Strikes a Nerve ]

A New Outlaw in the Levaquin Side Effects Corral

A New Outlaw in the Levaquin Side Effects Corral October 30, 2014. By Gordon Gibb.
Glendale, AZ Levaquin has long been a source of frustration for patients with regard to Levaquin side effects ranging from pain to tendon ruptures. But there is a new scourge emerging from the use of the fluoroquinolone that has actually been on the FDA radar since 2004, with an updated label finally coming last fall. Critics and plaintiffs say manufacturers and the US Food and Drug Administration aren’t doing enough.
Read [ A New Outlaw in the Levaquin Side Effects Corral ]

The Fluoroquinolones Community—and Their Leader Mark Girard

The Fluoroquinolones Community—and Their Leader Mark Girard August 30, 2014. By Brenda Craig.
Ottawa, ON Seven years ago Canadian Mark Girard was strong and healthy and living a very comfortable life. He worked as a chef in the high-altitude vacation lodges cradled in the pristine Rocky Mountains. On his days off, there was unlimited ATV riding surrounded by iconic scenery, and in the winter there were snowmobile adventures in the back country.
Read [ The Fluoroquinolones Community—and Their Leader Mark Girard ]

Investment Firm Wants Johnson & Johnson to Be Accountable for Levaquin Side Effects

Investment Firm Wants Johnson & Johnson to Be Accountable for Levaquin Side Effects January 24, 2012. By Charles Benson.
New Brunswick, NJ A California-based investment firm wants Johnson & Johnson to be held accountable for tendon injuries, irreversible nerve damage and other Levaquin side effects, The New Jersey Star-Ledger reported.
Read [ Investment Firm Wants Johnson & Johnson to Be Accountable for Levaquin Side Effects ]

Investors Want to Hold J&J's Feet to Levaquin Tendon Fire

Investors Want to Hold J&J's Feet to Levaquin Tendon Fire January 14, 2012. By Gordon Gibb.
Newark, NJ It seems like Johnson & Johnson (J&J), the makers of Levaquin through its subsidiary, Janssen Pharmaceuticals, has more to worry about than tens of thousands of levaquin lawsuits. Now, in a move that is not unprecedented but is nonetheless rare, an investment firm with shares in J&J is trying to force the manufacturer to be held accountable for levaquin side effects and other injuries allegedly triggered by the powerful antibiotic.
Read [ Investors Want to Hold J&J's Feet to Levaquin Tendon Fire ]

Page: 1  2     Next»

Request Legal Help Now! - Free